Page last updated: 2024-12-11

zr-512

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethyl-3,7,11-trimethyl-2,4-dodecadienoate: an insect growth regulator; RN given refers to (E,E)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

hydroprene : The ethyl ester of (2E,4E)-3,7,11-trimethyldodeca-2,4-dienoic acid [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5372477
CHEMBL ID37754
CHEBI ID39234
SCHEMBL ID20862
SCHEMBL ID2231130
MeSH IDM0049074

Synonyms (57)

Synonym
36557-30-9
ent 70459
ethyl 3,7,11-trimethyldodecene-2,4-dienoate
altozar
2,4-dodecadienoic acid, 3,7,11-trimethyl-, ethyl ester
2,4-dodecadienoic acid, 3,7,11-trimethyl-, ethyl ester, (e,e)-
egyt 2669
ethyl (2e,4e)-3,7,11-trimethyl-dodeca-2-4-dienoate
3,7,11-trimethyl-2,4-dodecadienoic acid ethyl ester
entacone
dodeca-2,4-dienoic acid, 3,7,11-trimethyl-, ethyl ester, (2e,4e)-
hsdb 6674
altozar igr
oms 1696
caswell no. 456h
hydroprene [ansi]
epa pesticide chemical code 486300
ethyl-3,7,11-trimethyldodeca-2,4-dienoate
NCGC00160417-01
ethyl 3,7,11-trimethyl-trans-2,trans-4-dodecadienoate
ethyl (2e,4e)-3,7,11-trimethyl-2,4-dodecadienoate
CHEBI:39234 ,
41096-46-2
(2e,4e)-hydroprene
hydroprene
(2e,4e)-3,7,11-trimethyldodeca-2,4-dienoic acid, ethyl ester
gencor
ethyl (e,e)-(+-)-3,7,11-trimethyl-2,4-dodecadienoate
ethyl (2e,4e)-3,7,11-trimethyldodeca-2,4-dienoate
zr 512
(rs)-hydroprene
(e,e)-3,7,11-trimethyl-2,4-dodecadienoic acid, ethyl ester
ethyl (e,e)-3,7,11-trimethyl-2,4-dodecadienoate
CHEMBL37754
STK677199
AKOS005594512
C18862
ethyl(2e,4e)-3,7,11-trimethyl-2,4-dodecadienoate
ethyl-3,7,11-trimethyl-2,4-dodecadienoate
unii-3ss174b1y9
2,4-dodecadienoic acid, 3,7,11-trimethyl-, ethyl ester, (2e,4e)-
hydroprene [ansi:iso]
3ss174b1y9 ,
hydroprene [iso]
sha-486300
dl-ethyl 3,7,11-trimethyl-trans-trans-2,4-dodecadienoate
hydroprene, (+/-)-
hydroprene [mi]
oms-1696
zr-512
gentrol
SCHEMBL20862
SCHEMBL2231130
DTXSID9042049
Q5955367
mfcd00233106
1ST20566

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response studies on diapausing pupal glands showed that ecdysone was the most effective activator."( Short-loop negative and positive feedback on ecdysone secretion by prothoracic gland in the tobacco hornworm, Manduca sexta.
Sakurai, S; Williams, CM, 1989
)
0.28
" We evaluated the potential of hydroprene and methoprene to be incorporated into an ingestible bait, with dose-response studies on fifth-instar male and female bed bugs."( Lethal and Sublethal Effects of Ingested Hydroprene and Methoprene on Development and Fecundity of the Common Bed Bug (Hemiptera: Cimicidae).
Schal, C; Sierras, A, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
juvenile hormone mimicnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
farnesane sesquiterpenoid
ethyl esterAny carboxylic ester resulting from the formal condensation of the carboxy group of a carboxylic acid with ethanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID23280Partition coefficient (logP)1984Journal of medicinal chemistry, Nov, Volume: 27, Issue:11
Quantitative structure-activity relationship of insect juvenile hormone mimetic compounds.
AID227700Anticonvulsant activity2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
AID220245Juvenile hormone mimetic activity in Tenebrio molitor (yellow mealworm)1984Journal of medicinal chemistry, Nov, Volume: 27, Issue:11
Quantitative structure-activity relationship of insect juvenile hormone mimetic compounds.
AID220250Juvenile hormone mimetic activity in Aedes aegypti (yellow-fever mosquito)1984Journal of medicinal chemistry, Nov, Volume: 27, Issue:11
Quantitative structure-activity relationship of insect juvenile hormone mimetic compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (49)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (28.57)18.7374
1990's13 (26.53)18.2507
2000's18 (36.73)29.6817
2010's3 (6.12)24.3611
2020's1 (2.04)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.31 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other54 (98.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]